Business Wire

emnify and Skylo to Unveil the First Converged Cellular and Satellite Connectivity at Mobile World Congress

Share

Today, emnify the leader in cloud-native IoT connectivity solutions, and Skylo, a global software-defined non-terrestrial network (NTN) operator focusing on connecting everything, everywhere, announce an industry-first convergence of satellite and cellular IoT connectivity from a single emnify SIM. Partnering with leading module manufacturer, Murata, the companies are expanding the next generation of IoT connectivity to space. The combination of emnify’s cloud-native, mobile core technology and direct IoT cellular access with providers around the globe, with Skylo’s NTN satellite access, provides seamless, intelligent, friction-free, network IoT connectivity.

The emnify IoT SuperNetwork, the industry’s first cloud-native IoT connectivity service with direct access to over 540 cellular networks in over 180 countries, provides access to Skylo’s satellite NTN services, marking the first and only single SIM access to global IoT connectivity on terrestrial and non-terrestrial networks. This innovation drastically reduces the operational cost and complexity of adding satellite connectivity, delivering on the promise of converged IoT connectivity to meet the needs of scaling IoT businesses, regardless of geographical challenges or local network infrastructure limitations.

"Our collaboration with Skylo underscores our commitment to expanding the SuperNetwork to create new opportunities and open new markets for IoT businesses everywhere," said Frank Stoecker, CEO and emnify founder. "The addition of satellite connectivity exemplifies the power of the SuperNetwork to go beyond traditional networks to provide dedicated IoT connectivity with truly global reach.”

Skylo, the leader in satellite connectivity, shares in the excitement. “We are thrilled to partner with emnify to offer friction-free access to NTN, ensuring that businesses are always connected for critical needs,” said Parthsarathi Trivedi, CEO and Skylo co-founder. "This innovation in IoT connectivity provides new levels of reliability and device availability, expanding IoT’s reach to previously inaccessible areas, and bringing new use cases to life."

“It’s critical that IoT customers have reliable, cost-effective, integrated hardware solutions to take advantage of innovations in IoT connectivity,” said Mehul Udani, Vice President Corporate Technology and Innovation for Murata. “Murata’s combined cellular and NTN radio modules provide a breakthrough in offering converged connectivity around the globe.”

Transformative use cases highlight converged IoT connectivity potential

Remote Monitoring Systems

In remote regions lacking traditional infrastructure, the unparalleled reach of the SuperNetwork with Skylo’s NTN satellite connectivity will enable reliable monitoring of water resources. The SuperNetwork ensures that sensors always use the appropriate network in their location.

According to Matt Trumbo, Director of Product Management for In-Situ, “For our markets, NTN effectively means you can use your cellular devices anywhere – no worrying about coverage, no hassles with local providers and network compatibility. It’s the benefits of traditional satellite data providers at an order of magnitude less in cost and in power consumption. NTN will completely alter how we partner with our customers to create decision-quality information.”

Asset Tracking

The SuperNetwork’s advanced reach and reliability with Skylo’s NTN satellite connectivity is necessary to enable breakthrough use cases and opportunities in asset tracking. High value assets are often stationed permanently or temporarily in remote, previously unconnected areas. Powered by a single emnify SIM, IoT tracking devices and sensors provide continuous data to monitor equipment location, movement and critical telemetry needed for services such as predictive maintenance, usage optimization, and security.

“We're excited about the possibility of merging satellite and cellular connectivity for GPS tracking in remote and rural areas. It's a compelling solution that extends our tracking capabilities to places where conventional cell networks can't reach. This innovation not only broadens our service coverage but also ensures connectivity in the most remote locations, enhancing the reliability of our GPS tracking solutions,” said Adam Ben Jacob Director of Sales, Support & Technology for OneStep GPS. “Our team is eager to dive into testing and deployment.”

New SuperNetwork Eval Program

emnify and Skylo are offering a new evaluation program for customers interested in deploying converged cellular and satellite connectivity. This program will allow selected participants to work directly with emnify and Skylo to test their use cases and the capabilities of the SuperNetwork to jumpstart their converged IoT connectivity transformation with hands-on support and guidance from a team of IoT experts.

Deploying IoT Satellite Roundtable at Mobile World Congress, Las Vegas

emnify is hosting an invite-only roundtable discussion on September 26, from 2:30-5:30. The roundtable, moderated by Matt Hatton, founding partner at Transforma Insights, features speakers from Skylo and Murata to discuss this next level of connectivity and how IoT businesses can take advantage of increased availability, lower power consumption, and a limitless footprint.

To register your interest in attending the roundtable please visit https://www.mwclasvegas.com/agenda/session/deploying-iot-satellite-in-2024-discover-new-technologies-to-expand-your-iot-connectivity.

To learn more about converged cellular and satellite IoT connectivity and the SuperNetwork, stop by the emnify booth, #839, at Mobile World Congress.

For more information and updates on the event please visit https://www.emnify.com/events/mwc-las-vegas-2023.

About emnify

emnify is the leading cloud building block for cellular communications in the IoT stack, connecting millions of IoT devices globally – from electric vehicles to energy meters, alarm systems to GPS trackers, thermometers to health wearables. The emnify API and SIM technology connect and secure any kind of IoT deployment to its application back-end. emnify’s cloud-native integrations and no-code workflows ensure seamless lifecycle scalability for deployments of all sizes – from start-up to enterprise. The award-winning emnify IoT SuperNetwork is the largest globally distributed mobile cloud core network of its kind, supporting local network access (2G – 5G, LTE-M, NB-IoT and satellite) in over 180 countries from more than 25 cloud regions – and counting. emnify’s solution is built on partnerships with the leading hyperscale cloud service providers, system integrators, and hundreds of network operators worldwide.

About Skylo

Skylo Technologies is an NTN service provider based in Mountain View, CA, offering a service that allows smartphone and IoT cellular devices to connect directly over existing satellites. Devices connected over satellite are managed and served by Skylo’s commercial NTN vRAN, featuring a 3GPP standards-based cloud-native base station and core. Skylo works with existing satellite operators, terrestrial mobile network operators, and device makers to provide subscribers an anywhere, anytime connectivity solution that seamlessly roams between terrestrial and satellite networks. Skylo’s focus is on enabling connected services for people outdoors and connected workflows for machines at work across critical industries such as agriculture, maritime, logistics, mining, and others, in addition to mass-market consumer devices. For more information, visit www.skylo.tech, contact info@skylo.tech, or follow us on LinkedIn and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

emnify Media Relations Contact:
Jennifer Baisch
emnify
media@emnify.com

Skylo Media Relations Contact:
Rosa Lear
Skylo Technologies
press@skylo.tech

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye